Burden of residual risk: Are triglycerides a risk marker? - PACE-CME

Burden of residual risk Are triglycerides a risk marker

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Icosapent ethyl in post-CABG patients with diabetes
Icosapent ethyl in post-CABG patients with diabetes
Hyperlipidemia
Icosapent ethyl in post-CABG patients with diabetes
- Subodh Verma, MD, PhD
Phase 3 study results of plozasiran in patients with FCS
Phase 3 study results of plozasiran in patients with FCS
Hyperlipidemia
Phase 3 study results of plozasiran in patients with FCS
- Gerald F. Watts, DSc, DM, PhD
Favorable effects of evolocumab on plaque characteristics in severe carotic artery stenosis
Favorable effects of evolocumab on plaque characteristics in severe carotic artery stenosis
ESC Congress 2024
Favorable effects of evolocumab on plaque characteristics in severe carotic artery stenosis
- C. David Mazer, MD
Predicting 30-year CV outcomes in women
Predicting 30-year CV outcomes in women
ESC Congress 2024
Predicting 30-year CV outcomes in women
- Paul Ridker, MD